Efficacy and Tolerability of Imiquimod 5% Cream to Treat Periocular Basal Cell Carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Tolerability of Imiquimod 5% Cream to Treat Periocular Basal Cell Carcinomas

Published:2010-08 Issue:4 Volume:26 Page:373-379
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Garcia-Martin Elena¹²,Idoipe Miriam¹,Gil Laura Maria¹,Pueyo Victoria¹²,Alfaro Jorge³,Pablo Luis E.¹²,Zubiri Maria Luisa⁴,Fernandez Javier¹

Affiliation:

1. Ophthalmology Department, Miguel Servet Universitary Hospital, Zaragoza, Spain.

2. Instituto Aragonés de Ciencias de la Salud, Miguel Servet Universitary Hospital, Zaragoza, Spain.

3. Pathologic Anatomy Department, Miguel Servet Universitary Hospital, Zaragoza, Spain.

4. Dermatology Department, Miguel Servet Universitary Hospital, Zaragoza, Spain.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2010.0030

Reference35 articles.

1. Basal Cell Carcinomas of the Eyelids

2. Incidence of Basal Cell and Squamous Cell Carcinomas in a Population Younger Than 40 Years

3. Trends in non-melanocytic skin cancer treated in Australia: The second national survey

4. Factors Affecting the Recurrence Rate of Basal Cell Carcinoma

5. Excision of Periocular Basal Cell Carcinoma With Stereoscopic Microdissection of Surgical Margins for Frozen-Section Control

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapeutic options for periorbital and orbital cutaneous basal and squamous cell carcinomas;Orbit;2022-10-10

2. Oncolytic Drugs;Drug-Induced Ocular Side Effects;2021

3. Topical Imiquimod as a Treatment Option for Nodular Basal Cell Carcinoma: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2020-06-11

4. Periocular basal cell carcinoma - clinical perspectives;Oncology Reviews;2020-04-30

5. Ocular Tumors;Abeloff's Clinical Oncology;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3